Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
30%
Ph phase_3
2
20%
Ph phase_1
5
50%

Phase Distribution

5

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
5(50.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
2(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (50.0%)
Phase 23 (30.0%)
Phase 32 (20.0%)

Trials by Status

not_yet_recruiting110%
withdrawn110%
completed880%

Recent Activity

0 active trials
Showing 5 of 10
not_yet_recruitingphase_3

Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study

NCT05809908
completedphase_1

Tricaprilin Infantile Spasms Pilot Study

NCT04727970
completedphase_2

Tricaprilin Phase 2 Pilot Study in Migraine

NCT04437199
withdrawnphase_3

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

NCT04187547
completedphase_2

Tricaprilin in Mild to Moderate Alzheimer's Disease

NCT00142805
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT05809908Phase 3

Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study

Not Yet Recruiting
NCT04727970Phase 1

Tricaprilin Infantile Spasms Pilot Study

Completed
NCT04437199Phase 2

Tricaprilin Phase 2 Pilot Study in Migraine

Completed
NCT04187547Phase 3

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Withdrawn
NCT00142805Phase 2

Tricaprilin in Mild to Moderate Alzheimer's Disease

Completed
NCT00355550Phase 2

Tricaprilin In Age-Associated Memory Impairment

Completed
NCT04268953Phase 1

Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production

Completed
NCT03971123Phase 1

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Completed
NCT03628352Phase 1

Taste-masking Study for Tricaprilin in Sensory Panelists

Completed
NCT03551769Phase 1

Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10